Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.390
+0.030 (8.25%)
Sep 16, 2024, 3:59 PM EDT
Elite Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 19.58 | 20.11 | 3.56 | 8.9 | 5.09 | -2.24 | Upgrade
|
| Depreciation & Amortization | 1.7 | 1.47 | 1.33 | 1.42 | 1.51 | 1.5 | Upgrade
|
| Other Amortization | 0 | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.05 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.29 | - | - | - | Upgrade
|
| Stock-Based Compensation | 6.79 | 6.75 | 0.58 | 0.78 | 0.94 | 1.03 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.15 | 0.24 | - | - | - | - | Upgrade
|
| Other Operating Activities | -17.31 | -19.97 | -0.43 | -3.6 | -2.25 | 1.11 | Upgrade
|
| Change in Accounts Receivable | -14.43 | -16.6 | -0.04 | 0.44 | 0.61 | -2.79 | Upgrade
|
| Change in Inventory | -2.66 | -3.38 | -2.81 | -1.73 | -0.87 | 0.37 | Upgrade
|
| Change in Accounts Payable | 8.25 | 7.78 | 1.34 | 0.31 | -1.77 | 0.34 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.01 | -0.18 | -1.16 | Upgrade
|
| Change in Other Net Operating Assets | 0.52 | 0.31 | -0.5 | -0.02 | 0.15 | 0.02 | Upgrade
|
| Operating Cash Flow | 2.57 | -3.28 | 3.34 | 6.51 | 3.19 | -1.79 | Upgrade
|
| Operating Cash Flow Growth | 116.85% | - | -48.70% | 103.78% | - | - | Upgrade
|
| Capital Expenditures | -1.59 | -0.81 | -5.74 | -0.5 | -0.33 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | - | - | - | 0.07 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.9 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | -2.47 | -0.81 | -5.74 | -0.5 | -0.26 | -0.03 | Upgrade
|
| Short-Term Debt Issued | - | 4 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 14.44 | - | 1.01 | - | Upgrade
|
| Total Debt Issued | - | 4 | 14.44 | - | 1.01 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.66 | -12.74 | -0.67 | -1.93 | -0.75 | Upgrade
|
| Total Debt Repaid | -0.79 | -0.66 | -12.74 | -0.67 | -1.93 | -0.75 | Upgrade
|
| Net Debt Issued (Repaid) | -0.79 | 3.34 | 1.7 | -0.67 | -0.91 | -0.75 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.04 | 1.44 | Upgrade
|
| Other Financing Activities | 0.05 | 0.05 | - | - | - | - | Upgrade
|
| Financing Cash Flow | -0.75 | 3.39 | 1.7 | -0.67 | -0.87 | 0.69 | Upgrade
|
| Net Cash Flow | -0.65 | -0.71 | -0.7 | 5.34 | 2.06 | -1.14 | Upgrade
|
| Free Cash Flow | 0.98 | -4.09 | -2.4 | 6.01 | 2.86 | -1.83 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 109.85% | - | - | Upgrade
|
| Free Cash Flow Margin | 1.48% | -7.23% | -7.02% | 18.63% | 11.28% | -10.16% | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | 0.01 | 0.00 | -0.00 | Upgrade
|
| Cash Interest Paid | 0.22 | 0.12 | 1.1 | 0.18 | 0.18 | 0.24 | Upgrade
|
| Cash Income Tax Paid | - | 0.03 | 0.42 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -1.65 | -4.92 | -4.55 | 3.6 | 1.11 | -2.33 | Upgrade
|
| Unlevered Free Cash Flow | -1.2 | -4.55 | -3.87 | 3.71 | 1.26 | -2.12 | Upgrade
|
| Change in Net Working Capital | 15.35 | 18.71 | 1.98 | 0.4 | 1.25 | 2.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.